Year 2019, Volume 58 , Issue , Pages 38 - 42 2019-10-25

Romatolojik hastalıklarda fibromiyaljinin payı
The role of fibromyalgia in rheumatic diseases

Arzu On [1]


Fibromiyalji sendromu (FMS), kronik yaygın kas-iskelet ağrısı, yaygın hassas noktalar, multipl somatik ve bilişsel problemlerle karakterize, spesifik laboratuvar ve görüntüleme bulgusu olmayan klinik bir sendromdur. Kronik romatolojik hastalıklarda FMS prevalansının genel popülasyona göre daha yüksek olduğu gösterilmiştir. Komorbid FMS hastalık aktivite skorlarının yükselmesine, dolayısıyla romatolojik hastalığın şiddetinin yanlış değerlendirilmesine ve gereksiz tedavilerin verilmesine neden olabilir. Bu nedenle eşlik eden FMS’nun tanınması, romatolojik hastalığın optimal tedavisi için önem taşır. Komorbid FMS olan olgularda hastalık aktivite göstergeleri dikkatle yorumlanmalı, objektif klinik ölçütler göz önünde bulundurulmalıdır. Bu derlemede, değişik romatolojik hastalıklarda komorbid FMS prevalansı, patofizyolojisi ve altta yatan inflamatuvar hastalık üzerindeki etkileri gözden geçirilecektir.

Fibromyalgia syndrome (FMS) is a clinical disorder characterized by chronic diffuse musculoskeletal pain, numerous discrete tender points and multiple somatic and cognitive symptoms, without any specific laboratory and imaging findings. Prevalence of FMS is higher in chronic inflammatory arthritis, compared to the general population. Comorbid FMS may lead to increased disease activity scores, leading to an inaccurate impression of disease severity. Thus, it is important to recognize comorbid FMS for the optimal management of rheumatic diseases. Disease activity indices should be cautiously interpreted, and objective clinical measurements should be considered in patients with comorbid FMS. In this review, the prevalence and pathophysiology of concomitant FMS in different rheumatic diseases and its impact on underlying inflammatory condition will be highlighted.

  • Wolfe F, Hugh A. Smythe, et al. The American Collage of Rheumatology 1990 Criteria for The Classification of Fibromyalgia. Arthritis Rheum 1990;33(1):24-32.
  • Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalance and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38(1):19-28.
  • Inanici F, Yunus MB. History of fibromyalgia: past to present. Curr Pain Headache Rep 2004;8(5):369-78.
  • William S, Wılke MD. New developments in the diagnosis of fibromyalgia syndrome: Say goodbye to tender points? Cleve Clin J Med 2009;76:345-52.
  • Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American Collage of Rheumatology Preliminary Diagnostic Criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010;62 (5):600-10.
  • Wolfe F, Clauw DJ, Fitzcharles MA et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol 2011;38(6):1113-22.
  • White KP, Speechley M, Harth M, Ostbye T. The London Fibromyalgia Epidemiology Study: the prevalance of fibromyalgia syndrome in London, Ontorio. J Rheumatol 1999;26:1570-6.
  • Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalance and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38(1):19-28.
  • Topbaş M, Çakırbay H, Güleç H, et al. The prevalence of fibromyalgia in women aged 20-64 in Turkey. Scand J Rheumatol 2005;34 (2):140-4.
  • Sarzi-Puttini P, Atzeni F, Mease PJ. Choronic widespread pain: from peripheral to central evolution. Best Pract Res Clin Rheumatol 2011;25:133-9.
  • Schmidt-Wilcke T, Clauw DJ. Fibromyalgia: from pathophysiology to therapy. Nat Rev Rheumatol 2011;7:518-27. Ege Tıp Dergisi / Ege 42 Journal of Medicine
  • Staud R, Cannon RC, Mauderli AP, et al. Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome. Pain 2003;102 (1-2): 87-95.
  • Gracely RH, Petzke F, Wolf JM, et al. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002;46: 1333-43.
  • Cook DB, Lange G, Ciccone DS, et al. Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol 2004;31:364-78.
  • Yunus MB. Central sensitivity syndromes: A new paradigm and group nosology for fibromyalgia and overlapping conditions and the related issue of disease versus illness. Semin Arthritis Rheum 2008;37(6):339-52.
  • On AY: Kronik ağrı etiyopatogenezi. Türkiye Klinikleri J PM&R-Special Topics 2017;10(3):234-41.
  • Cohen H. Controversies and challenges in fibromyalgia: a review and a proposal. Ther Adv Musculoskelet Dis 2017;9(5):115–127.
  • On AY. Fibromyalgia or chronic widespread pain: Does it matter? Itch & Pain 2016;3:e1079
  • On AY, Aykanat D, Atamaz FC, Eyigor C, Kocanogullari H, Oksel F. Is it necessary to strictly diagnose fibromyalgia syndrome in patients with chronic widespread pain? Clin Rheumatol 2015;34(8):1473-9.
  • Duffield SJ, Miller N, Zhao S, Goodson NJ. Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 2018; 57(8):1453-60.
  • Meeus M, Vervisch S, De Clerck LS, Moorkens G, Hans G, Nijs J. Central sensitization in patients with rheumatoid arthritis: a systematic literature review. Semin Arthritis Rheum 2012;41(4):556-67.
  • Lee YC, Bingham CO, Edwards RR, et al. Association between pain sensitization and disease activity in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Care Res (Hoboken). 2018;70(2):197-204.
  • Poleshuck EL, Katz J, Andrus CH, et al. Risk factors for chronic pain following breast cancer surgery: a prospective study. J Pain 2006;7(9):626–34.
  • Goldenberg DL, Clauw DJ, Fitzcharles MA. New concepts in pain research and pain management of the rheumatic diseases. Semin Arthritis Rheum 2011;41(3):319–34.
  • Mease PJ, Hanna S, Frakes EP, Altman RD. Pain mechanisms in osteoarthritis: understanding the role of central pain and current approaches to its treatment. J Rheumatol 2011;38 (8):1546–51.
  • Inglis JJ, Notley CA, Essex D, et al. Collagen-induced arthritis as a model of hyperalgesia: functional and cellular analysis of the analgesic actions of tumor necrosis factor blockade. Arthritis Rheum 2007 Dec;56(12):4015-23.
  • Edwards RR, Wasan AD, Bingham CO, et al. Enhanced reactivity to pain in patients with rheumatoid arthritis. Arthritis Res Ther 2009;11(3):R61.
  • Lee YC, Cui J, Lu B, et al. Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study. Arthritis Res Ther 2011 Jun 8;13(3):R83.
  • Lee YC, Chibnik LB, Lu B, et al. The relationship between disease activity, sleep, psychiatric distress and pain sensitivity in rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 2009;11(5):R160.
  • Lee YC, Lu B, Boire G, et al. Incidence and predictors of secondary fibromyalgia in an early arthritis cohort. Ann Rheum Dis 2013;72(6):949-54.
  • Gist AC, Guymer EK, Eades LE, Leech M, Littlejohn GO. Fibromyalgia remains a significant burden in rheumatoid arthritis patients in Australia. Int J Rheum Dis 2018;21(3):639-646.
  • Lee YC, Bingham CO, Edwards RR, et al. Association Between Pain Sensitization and Disease Activity in Patients With Rheumatoid Arthritis: A Cross-Sectional Study. Arthritis Care Res (Hoboken) 2018;70(2):197-204.
  • Gheita TA, El-Rabbat SM, Mahmoud NK. Fibromyalgia and rheumatic diseases. Fibrom Open Access 2017;2:116.
  • Haliloglu S, Carlioglu A, Akdeniz D, Karaaslan Y, Kosar A. Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity. Rheumatol Int 2014;34(9):1275-80.
  • Torrente-Segarra V, Corominas H, Sanchez-Piedra C, et al. Fibromyalgia prevalence and associated factors in primary Sjögren's syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER). Clin Exp Rheumatol 2017;35(Suppl 105-3):28-34.
  • Yavuz S, Fresko I, Hamuryudan V, Yurdakul S, Yazici H. Fibromyalgia in Behçet's syndrome. J Rheumatol 1998;25:2219-20.
  • Melikoglu M, Melikoglu MA. The prevalence of fibromyalgia in patients with Behçet's disease and its relation with disease activity. Rheumatol Int 2013;33:1219-22.
  • Lee SS, Yoon HJ, Chang HK, Park KS. Fibromyalgia in Behçet’s disease is associated with anxiety and depression, and not with disease activity. Clin Exp Rheumatol 2005;(4 Suppl 38):S15-9.
Primary Language tr
Subjects Health Care Sciences and Services
Journal Section Supplement
Authors

Orcid: 0000-0002-7305-0186
Author: Arzu On (Primary Author)
Institution: Ege Üniversitesi Tıp Fakültesi Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı
Country: Turkey


Dates

Publication Date : October 25, 2019

Bibtex @other { etd648902, journal = {Ege Tıp Dergisi}, issn = {1016-9113}, eissn = {2147-6500}, address = {}, publisher = {Ege University}, year = {2019}, volume = {58}, pages = {38 - 42}, doi = {10.19161/etd.648902}, title = {Romatolojik hastalıklarda fibromiyaljinin payı}, key = {cite}, author = {On, Arzu} }
APA On, A . (2019). Romatolojik hastalıklarda fibromiyaljinin payı. Ege Tıp Dergisi , 58 () , 38-42 . DOI: 10.19161/etd.648902
MLA On, A . "Romatolojik hastalıklarda fibromiyaljinin payı". Ege Tıp Dergisi 58 (2019 ): 38-42 <http://egetipdergisi.com.tr/en/issue/50237/648902>
Chicago On, A . "Romatolojik hastalıklarda fibromiyaljinin payı". Ege Tıp Dergisi 58 (2019 ): 38-42
RIS TY - JOUR T1 - Romatolojik hastalıklarda fibromiyaljinin payı AU - Arzu On Y1 - 2019 PY - 2019 N1 - doi: 10.19161/etd.648902 DO - 10.19161/etd.648902 T2 - Ege Tıp Dergisi JF - Journal JO - JOR SP - 38 EP - 42 VL - 58 IS - SN - 1016-9113-2147-6500 M3 - doi: 10.19161/etd.648902 UR - https://doi.org/10.19161/etd.648902 Y2 - 2019 ER -
EndNote %0 Ege Tıp Dergisi Romatolojik hastalıklarda fibromiyaljinin payı %A Arzu On %T Romatolojik hastalıklarda fibromiyaljinin payı %D 2019 %J Ege Tıp Dergisi %P 1016-9113-2147-6500 %V 58 %N %R doi: 10.19161/etd.648902 %U 10.19161/etd.648902
ISNAD On, Arzu . "Romatolojik hastalıklarda fibromiyaljinin payı". Ege Tıp Dergisi 58 / (October 2019): 38-42 . https://doi.org/10.19161/etd.648902
AMA On A . Romatolojik hastalıklarda fibromiyaljinin payı. Ege Tıp Dergisi. 2019; 58: 38-42.
Vancouver On A . Romatolojik hastalıklarda fibromiyaljinin payı. Ege Tıp Dergisi. 2019; 58: 42-38.